All of these findings support the hypothesis that ectopic expression of AGGF1 promotes CRC metastasis, serving as a potential therapeutic target for CRC patients, especially for patients with lung and liver metastasis. The gene discussed is AGGF1; the disease is colorectal carcinoma.